Randomized Comparison of Cardiotoxicity With 60 Versus 90 mg Daunorubicin in AML Induction Therapy. Dendorfer SM, Schmidt-Brucken K, Kramer M, Steffen B, et al. Am J Hematol 2026;101:512-520.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Dendorfer SM, Schmidt-Brucken K, Kramer M, Steffen B, et al. Randomized Comparison of Cardiotoxicity With 60 Versus 90 mg Daunorubicin in AML Induction Therapy. Am J Hematol 2026;101:512-520.
PMID: 41492073